C3orf85: A Potential Drug Target Or Biomarker (G401081)

Target Name: C3orf85

NCBI ID: G401081

C3orf85

Other Name(s): Chromosome 3 open reading frame 85, transcript variant 2 | Uncharacterized protein C3orf85 (isoform 2) precursor | chromosome 3 open reading frame 85 | C3orf85 variant 2

C3orf85: A Potential Drug Target Or Biomarker

C3orf85, also known as Chromosome 3 open reading frame 85, is a gene that is located on chromosome 3 and is encoding a protein, specifically a protein known as CRL3 (C3-like protein 3). CRL3 is a cytoplasmic protein that is involved in a variety of cellular processes, including the regulation of cell adhesion, the cytoskeleton, and the cell cycle.

In recent years, researchers have become increasingly interested in C3orf85 as a potential drug target or biomarker. This is because the C3-like protein 3 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key reasons for the interest in C3rf85 is its location on chromosome 3, which is known as the "X banding" in females and the "Y banding" in males. This means that any changes in the C3-like protein 3 gene have the potential to affect a wide range of tissues and organs, including those in the brain, spinal cord, and reproductive system.

In addition, C3rf85 has been shown to be involved in a variety of cellular processes that are important for the growth, differentiation, and survival of cells. For example, studies have shown that C3rf85 plays a role in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

C3rf85 is also involved in the regulation of the cytoskeleton, which is the structure that gives cells their shape and helps them move and function. This is important for the development and maintenance of tissues and organs, as well as for the movement of cells through the body.

In addition to its role in cell regulation, C3rf85 has also been shown to be involved in the regulation of the cell cycle. This is the process by which cells grow, divide, and replicate themselves, and is important for the growth and development of tissues and organs.

The potential drug targets for C3rf85 are vast, as the C3-like protein 3 has been shown to play a role in a wide range of diseases and conditions. For example, C3rf85 has been shown to be involved in the development and progression of cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, C3rf85 has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that C3rf85 levels are elevated in a variety of cancer types, including breast, ovarian, and prostate cancer. This suggests that C3rf85 may be a useful biomarker for these diseases, and could potentially be used as a diagnostic tool.

Overall, C3rf85 is a gene that has the potential to be a drug target or biomarker, and its study is being actively explored by researchers. Further research is needed to fully understand the role of C3rf85 in various cellular processes and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: Chromosome 3 Open Reading Frame 85

The "C3orf85 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C3orf85 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets